Nature S Sunshine Products Inc (NATR) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Nature s Sunshine Products inc   (NASDAQ: NATR)
 

Nature S Sunshine Products Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Nature S Sunshine Products Inc 's inventory turnover ratio sequentially decreased to 1.92 in the second quarter 2026, unsurprisingly, as the Nature S Sunshine Products Inc markets continue to deteriorate, and NATR's faces growing challenges to bring down its inventories. Nature S Sunshine Products Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 190 days, from 186 days, in the Mar 31 2026 quarter.

Within Healthcare sector 215 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1602, from total ranking in the first quarter 2026 at 1792.

NATR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Nature S Sunshine Products Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NATR Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 3.48 % 3.39 % 14.92 % 8.09 % 11.26 %
Y / Y Cost of Sales Growth -3.72 % 3.23 % 5.61 % 6.25 % 3.23 %
Inventory Turnover Ratio (TTM) 1.92 1.96 1.96 1.99 2
NATR's Total Ranking # 1602 # 1792 # 1611 # 1609 # 1596
Average inventory processing period 190 187 187 183 182
Seq. Inventory Growth 6.85 % -1.73 % 1.45 % -2.86 % 6.76 %
Seq. Cost of Sales Growth -3.72 % -8.57 % 2.94 % 6.25 % 3.23 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 62
Healthcare Sector # 216
Overall Market # 1602

Inventory Turnover Ratio Statistics
High Average Low
2.28 2.05 1.74
(Dec 31 2014)   (Mar 31 2023)



NATR Company Profile >> Back to NATR Efficiency Comparisons >> Compare NATR Inventory Turnover Ratio to its Competitors

Financial Statements
Nature S Sunshine Products Inc 's Inventories $ 72 Millions Visit NATR's Balance sheet
Nature S Sunshine Products Inc 's Cost of Revenues TTM $ 132 Millions Visit NATR's Income Statement
What are NATR's Sales? Visit NATR's Sales by Segment

Other Inventory Turnover Ratios
Nature S Sunshine Products Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NATR's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NATR's Competitors
Inventory Turnover Ratio for NATR's Suppliers
Inventory Turnover Ratio for NATR's Customers

You may also want to know
NATR's Sales Growth Rates NATR's Pe Price to earnings ratio NATR's Receivables Turnover Ratio NATR's Stock Quote
NATR's Net Income Growth Rates NATR's Ps Price to Sales ratio NATR's Sales per Employee NATR's Asset Turnover Ratio
NATR's Net Margin NATR's Pb Price to Book ratio NATR's Financial Strength Ratios NATR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Escalon Medical Corp   3.94 $ 7.167  Millions$ 2  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.